Skip to main content
Clinical Trials/NCT03118596
NCT03118596CompletedNot Applicable

Fibre-optic Guided Tracheal Intubation Through Supraglottic Airway Devices - a Randomised Comparison Between I-gel and the LMA ProtectorTM

University Hospitals Coventry and Warwickshire NHS Trust2 sites in 1 country180 target enrollmentStarted: May 24, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
180
Locations
2
Primary Endpoint
Total Intubation Time to Perform Fibreoptic Intubation

Study Overview

Brief Summary

The study aims to establish which of the two second generation Supraglottic Airway Devices, the I-gel or the the laryngeal ask airway (LMA) Protector, is best suited to be used as a conduit to fibreoptic bronchoscope assisted tracheal intubation. The primary outcome of this will be the time to complete the tracheal intubation.

Detailed Description

Tracheal intubation through a supraglottic airway device (SAD) is a well-established technique in the management of patients with a difficult airway. The technique can be used in patients in whom difficult intubation is expected, or in situations when tracheal intubation using another method was not possible. It is now recommended that tracheal intubation through the SAD should be performed using a fibreoptic scope (a camera device) to minimise the risk of trauma to the airway, and that second generation SADs are used to minimise the risk of aspiration of gastric contents.

There are two second generation SADs currently available which allow tracheal intubation: the I-gel and the LMA protector.

The I-gel is a second generation supraglottic airway device widely used in anaesthesia and resuscitation. Fibreoptic intubation through the I-gel has been evaluated in a recent prospective study (1), with the first attempt success rate of 91.4%. In another study (2) of patients with predicted difficult airway, the success rate of the procedure at first attempt was 96%.

LMA Protector is a recently introduced, improved version the LMA supreme - another second generation SAD. LMA supreme has been used in clinical practice for more than 10 years, however, tracheal intubation through the device was extremely difficult because of the small size of the breathing channel. The LMA Protector, has a larger breathing channel allowing the passage of an endotracheal tube. Compared to the I-gel, is has also got a larger gastric drainage tube. This allows easy suction in the event of regurgitation. Therefore, it appears to be superior to the I-gel in preventing the aspiration. But there are no studies comparing the ease of intubation through I-gel and LMA Protector

The aim of this study is to compare the ease of performing the fibreoptic guided tracheal intubation through these two devices. Our hypothesis is that intubation through the I-gel is easier and quicker.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients aged above 18, presenting for elective surgical procedure, where a supraglottic airway device can be used and left in place throughout the duration of surgery and requiring tracheal intubation

Exclusion Criteria

  • Patients who are do not wish to take part
  • Patients with class II obesity (BMI >40)
  • Patients below 18 years of age
  • American Society of Anaesthesiologists (ASA 3, 4 and 5)
  • Patients with mouth opening of less than 3 cm
  • Patients deemed to require awake intubation
  • Surgery involving head and neck region
  • Surgery requiring prone position

Arms & Interventions

I-gel

Active Comparator

Fibreoptic guided tracheal intubation through I-gel

Intervention: I-gel (Device)

LMA Protector

Active Comparator

Fibreoptic guided tracheal intubation through Protector

Intervention: LMA Protector (Device)

Outcomes

Primary Outcomes

Total Intubation Time to Perform Fibreoptic Intubation

Time Frame: less than 3 minutes

Time form insertion of bronchoscope through the supraglottic airway device to obtaining the capnography trace

Secondary Outcomes

  • Number of Attempts at the SAD Placement(less than 2 minutes)
  • Number of Participants With Ease of Placement of the SAD(less than 2 minutes)
  • Time to Carinal View(less than 1 minute)
  • Number of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,(less than 3 minutes)
  • SAD Insertion Time(less than 1 minute)
  • Number of Participants With First and Second Attempt at Tracheal Intubation(less than 3 minutes)
  • Number of Participants With Quality of the View of the Vocal Cords Seen Through the SAD(less than 3 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials